Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (1041-1050 of 6,943) with videos related to

Pageof 695
Sort By:
Cancer Science|July 21, 2007
Activation of both nuclear factor of activated T cells and inhibitor of nuclear factor-kappa B kinase beta-subunit-/nuclear factor-kappa B is critical for cyclooxygenase-2 induction by benzo[a]pyrene in human bronchial epithelial cellsJin Ding, Kangjian Wu, Dongyun Zhang, et al.
Cancer Science|July 25, 2007
Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cellsMakoto Osanai, Masaki Murata, Hideki Chiba, et al.
Cancer Science|July 25, 2007
Notch ligand Delta-1 differentially modulates the effects of gp130 activation on interleukin-6 receptor alpha-positive and -negative human hematopoietic progenitorsKentaro Yamamura, Kohshi Ohishi, Naoyuki Katayama, et al.
Cancer Science|July 25, 2007
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteinsMako Narisawa-Saito, Tohru Kiyono
Cancer Science|July 25, 2007
Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosisTatsushi Yoshida, Takumi Shiraishi, Mano Horinaka, et al.
Cancer Science|July 25, 2007
HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancerEiki Kikuchi, Koichi Yamazaki, Toshihiko Torigoe, et al.
Cancer Science|July 14, 2007
Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathwayKazuko Sakai, Hideyuki Yokote, Kimiko Murakami-Murofushi, et al.
Cancer Science|May 10, 2007
Condensin mutations and abnormal chromosomal structures in pyothorax-associated lymphomaMaria Francisca Ham, Tetsuya Takakuwa, Nur Rahadiani, et al.
Cancer Science|May 10, 2007
Serum M-spike and transplant outcome in patients with multiple myelomaDavid Dingli, Jorge M Pacheco, Angela Dispenzieri, et al.
Cancer Science|May 18, 2007
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancerPing He, Tetsuji Naka, Satoshi Serada, et al.
Pageof 695

Showing results (1041-1050 of 6,943) with videos related to

Sort By:
Pageof 695
Cancer Science|July 21, 2007
Activation of both nuclear factor of activated T cells and inhibitor of nuclear factor-kappa B kinase beta-subunit-/nuclear factor-kappa B is critical for cyclooxygenase-2 induction by benzo[a]pyrene in human bronchial epithelial cellsJin Ding, Kangjian Wu, Dongyun Zhang, et al.
Cancer Science|July 25, 2007
Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cellsMakoto Osanai, Masaki Murata, Hideki Chiba, et al.
Cancer Science|July 25, 2007
Notch ligand Delta-1 differentially modulates the effects of gp130 activation on interleukin-6 receptor alpha-positive and -negative human hematopoietic progenitorsKentaro Yamamura, Kohshi Ohishi, Naoyuki Katayama, et al.
Cancer Science|July 25, 2007
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteinsMako Narisawa-Saito, Tohru Kiyono
Cancer Science|July 25, 2007
Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosisTatsushi Yoshida, Takumi Shiraishi, Mano Horinaka, et al.
Cancer Science|July 25, 2007
HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancerEiki Kikuchi, Koichi Yamazaki, Toshihiko Torigoe, et al.
Cancer Science|July 14, 2007
Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathwayKazuko Sakai, Hideyuki Yokote, Kimiko Murakami-Murofushi, et al.
Cancer Science|May 10, 2007
Condensin mutations and abnormal chromosomal structures in pyothorax-associated lymphomaMaria Francisca Ham, Tetsuya Takakuwa, Nur Rahadiani, et al.
Cancer Science|May 10, 2007
Serum M-spike and transplant outcome in patients with multiple myelomaDavid Dingli, Jorge M Pacheco, Angela Dispenzieri, et al.
Cancer Science|May 18, 2007
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancerPing He, Tetsuji Naka, Satoshi Serada, et al.
Pageof 695